[	0	1	O
Autologous	1	11	O
bone	12	16	B-Cell
marrow	17	23	I-Cell
stem	24	28	I-Cell
cell	29	33	I-Cell
or	34	36	O
peripheral	37	47	B-Cell
blood	48	53	I-Cell
endothelial	54	65	I-Cell
progenitor	66	76	I-Cell
cell	77	81	I-Cell
therapy	82	89	O
in	90	92	O
patients	93	101	B-Organism
with	102	106	O
peripheral	107	117	O
limb	118	122	B-Organism_subdivision
ischaemia	123	132	O
]	132	133	O

No	135	137	O
effective	138	147	O
medical	148	155	O
therapies	156	165	O
have	166	170	O
been	171	175	O
developed	176	185	O
sofar	186	191	O
to	192	194	O
enhance	195	202	O
blood	203	208	B-Organism_substance
flow	209	213	O
in	214	216	O
the	217	220	O
legs	221	225	B-Organism_subdivision
of	226	228	O
patients	229	237	B-Organism
with	238	242	O
peripheral	243	253	O
arterial	254	262	O
disease	263	270	O
(	271	272	O
PAD	272	275	O
)	275	276	O
.	276	277	O

For	278	281	O
patients	282	290	B-Organism
with	291	295	O
limb	296	300	B-Organism_subdivision
threatening	301	312	O
ischaemia	313	322	O
the	323	326	O
only	327	331	O
option	332	338	O
for	339	342	O
relief	343	349	O
of	350	352	O
rest	353	357	O
pain	358	362	O
or	363	365	O
gangraena	366	375	O
is	376	378	O
amputation	379	389	O
.	389	390	O

There	391	396	O
is	397	399	O
evidence	400	408	O
in	409	411	O
experimental	412	424	O
and	425	428	O
clinical	429	437	O
studies	438	445	O
that	446	450	O
adult	451	456	O
bone	457	461	B-Cell
marrow	462	468	I-Cell
-	468	469	I-Cell
derived	469	476	I-Cell
stem	477	481	I-Cell
cells	482	487	I-Cell
and	488	491	O
endothelial	492	503	B-Cell
progenitor	504	514	I-Cell
cells	515	520	I-Cell
participate	521	532	O
in	533	535	O
the	536	539	O
development	540	551	O
of	552	554	O
new	555	558	O
blood	559	564	B-Multi-tissue_structure
vessels	565	572	I-Multi-tissue_structure
,	572	573	O
called	574	580	O
neoangiogenesis	581	596	O
or	597	599	O
neovascularization	600	618	O
.	618	619	O

Clinical	620	628	O
results	629	636	O
induced	637	644	O
by	645	647	O
autologous	648	658	O
bone	659	663	B-Cell
marrow	664	670	I-Cell
stem	671	675	I-Cell
cells	676	681	I-Cell
or	682	684	O
angiogenic	685	695	O
growth	696	702	O
/	702	703	O
differentiation	703	718	O
factors	719	726	O
in	727	729	O
end	730	733	O
-	733	734	O
stage	734	739	O
patients	740	748	B-Organism
with	749	753	O
PAD	754	757	O
are	758	761	O
summarized	762	772	O
.	772	773	O

Considering	774	785	O
the	786	789	O
relatively	790	800	O
few	801	804	O
number	805	811	O
of	812	814	O
patients	815	823	B-Organism
treated	824	831	O
by	832	834	O
angiogenic	835	845	O
therapy	846	853	O
,	853	854	O
the	855	858	O
interpretation	859	873	O
of	874	876	O
clinical	877	885	O
results	886	893	O
needs	894	899	O
cautiousness	900	912	O
.	912	913	O

